Bucharest, Romania – February 18, 2026 — ZayaAI, a provider of AI-powered digital pathology solutions, today announced that Joakim Jagorstrand has joined the company as Strategic Advisor and Chief Commercial Officer (CCO). In this dual role, Joakim will lead ZayaAI’s global commercial strategy, scaling go-to-market execution, partnerships, and enterprise adoption across Europe, the Middle East, Africa, Latin America and Asia-Pacific.
ZayaAI is building a next-generation digital pathology platform that integrates cloud-based Laboratory Information System (LIS) workflows, remote diagnosis, and embedded AI diagnostics—designed for scalability, compliance, and ease of adoption in both advanced clinical settings and emerging markets.
Joakim Jagorstrand brings decades of experience in global commercialization, business transformation, and leadership across medical technology, diagnostics, and pharmaceuticals, with a strong track record in oncology-focused innovation.
“ZayaAI has reached a point where product maturity and market pull require a step-change in commercial execution,” said Cristian Mogodici, CEO of ZayaAI. “Joakim’s proven leadership will convert our momentum into predictable growth—building channel partnerships, scaling enterprise sales, and translating our platform strengths into measurable outcomes for pathology labs. We’re excited to welcome him as both CCO and strategic advisor.”
“Pathology is undergoing a fundamental shift—digital workflows and AI augmentation are becoming essential infrastructure,” said Joakim Jagorstrand, Chief Commercial Officer & Advisor at ZayaAI. “ZayaAI’s approach—bringing AI directly into the pathologist’s workflow within a scalable LIS ecosystem—has the potential to shorten turnaround times, standardize quality, and expand access to advanced diagnostics. I look forward to working with the team to scale globally through focused execution and strong partnerships.”
Strategic Priorities
As CCO and Advisor, Joakim’s immediate focus includes:
- Global go-to-market scale-up: enterprise sales motion, pricing strategy, and pipeline management
- Channel and distribution alliances: partnering with scanner, viewer, and integrator providers to accelerate deployments.
- Strategic alliances: expanding the ecosystem of embedded AI applications and workflow integrations
- Customer success programs: emphasizing workflow efficiency, traceability, and operational scalability.
ZayaAI’s commercial expansion leverages a growing ecosystem of collaborations, embedding advanced AI directly into LIS workflows alongside leaders in digital pathology
About ZayaAI
ZayaAI offers a next-generation digital pathology platform integrating a cloud-based LIS, remote diagnosis, and embedded AI diagnostics. Its solutions are designed for scalability, compliance, and ease of use in both emerging markets and advanced clinical settings